Showing results (241-250 of 379) with videos related to
Sort By:
Pageof 38
American Journal of Respiratory and Critical Care Medicine|September 5, 2024
Lentiviral Gene Therapy for Cystic Fibrosis: A Promising Approach and First-in-Human TrialJane C Davies, Deepika Polineni, A Christopher Boyd, et al.International Journal of Molecular Sciences|August 12, 2023
Personalized CFTR Modulator Therapy for G85E and N1303K Homozygous Patients with Cystic FibrosisSimon Y Graeber, Anita Balázs, Niklas Ziegahn, et al.The European Respiratory Journal|October 28, 2024
Targeting neutrophil serine proteases in bronchiectasisJames D Chalmers, Marcus A Mall, Sanjay H Chotirmall, et al.The Journal of Allergy and Clinical Immunology|November 21, 2016
Impaired mucus clearance exacerbates allergen-induced type 2 airway inflammation in juvenile miceBenedikt Fritzsching, Matthias Hagner, Lu Dai, et al.Physical Review. E|March 17, 2017
Dephasing and diffusion on the alveolar surfaceL R Buschle, F T Kurz, T Kampf, et al.The European Respiratory Journal|September 18, 2025
Changes in Sputum Viscoelastic Properties and Airway Inflammation in Primary Ciliary Dyskinesia are Comparable to Cystic Fibrosis on Elexacaftor/Tezacaftor/Ivacaftor TherapyHannah Nussstein, Ruth M Urbantat, Kerstin Fentker, et al.Biomaterials Science|July 19, 2024
Thiolated polyglycerol sulfate as potential mucolytic for muco-obstructive lung diseasesJustin Arenhoevel, Aditi Kuppe, Annalisa Addante, et al.Plos One|June 13, 2015
Airway Surface Dehydration Aggravates Cigarette Smoke-Induced Hallmarks of COPD in MiceLeen J M Seys, Fien M Verhamme, Lisa L Dupont, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 18, 2026
Safety and efficacy of elexacaftor/tezacaftor/ivacaftor in children ≥2 years with cystic fibrosis: 96-week interim results from a phase 3 open-label extension studyJennifer L Goralski, Cori Daines, Jessica E Pittman, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 11, 2022
Magnetic resonance imaging detects improvements of pulmonary and paranasal sinus abnormalities in response to elexacaftor/tezacaftor/ivacaftor therapy in adults with cystic fibrosisLena Wucherpfennig, Simon M F Triphan, Sabine Wege, et al.Pageof 38